From 2 April - 2 May, National Pet Month will be encouraging people to get happy and healthy spending time with their pets, with its theme of 'Happiness is... time with your pet'.

Organisers say that during the month, thousands of people will be celebrating happy times with their pets at hundreds of events up and down the country. While many of these events will raise funds for local animal charities, National Pet Month is not just about fund raising. It is also all about raising awareness of how pets make people's lives happier and healthier, and how they can repay the pets they love by looking after them responsibly.

Veterinary practices can get involved in National Pet Month, and show what they have to offer clients and potential clients. Details of how to join in and become a supporter are on the website http://www.nationalpetmonth.org.uk/.

Last year's National Pet Month was apparently the most successful to date, with a record number of 1200 events and nearly £80,000 raised for at least 30 animal charities. 

The 2010 overall best National Pet Month event was held by St Boniface Vets in Crediton, Devon. They participated by visiting local nursery and primary schools teaching children about pet health, and specifically raising awareness of exotic animals as pets. Phil Sketchley, Chairman of NPM said: "The 14 excellent educational visits that St Boniface made to local schools and nurseries were inspirational. They were a fantastic example of the partnerships that can be forged between practices and the community during National Pet Month."

He added: "School visits are one great way for practices to get involved - but there are many more. Our top veterinary practice 2010 event, for example, was held by Mill House Vets in Kings Lynn, and which focussed on educating owners on caring for older pets. National Pet Month is an opportunity to help your clients learn more about responsible pet care so they can enjoy their pets for many years to come."

Hill's Pet Nutrition is offering a series of free webinars about feline medicine, delivered by some of the best-known experts in the field.

The first presentation on feline liver disease will be delivered by Danièlle Gunn-Moore BVM&S BSc PhD MACVSc MRCVS, on the 26th January 2011. Martha Cannon BA VetMB DSAM(fel) MRCVS (pictured right) will present the next two webinars on Renal disease on 2nd March and Chronic Diarrhoea on 4th May. Both speakers are RCVS Specialists in feline medicine. Norman Johnston BVM&S, Dipl. AVDC, Dipl. EVDC, MRCVS, will be discussing stomatitis in the cat - a particularly problematic disease - on the 18th May. Norman is an RCVS, American and European Specialist in Veterinary Dentistry. The series will end on 8th June with Duncan Lascelles BSc, BVSc, PhD, CertVA, DSAS (ST), DECVS, DACVS, Associate Professor in Small Animal Surgery at North Carolina State, talking about osteoarthritis in the cat.

The events kick off at 8.30 pm and are hosted by the Webinar Vet (www.thewebinarvet.com). One initial registration provides access to the complete series, with scheduled e-mail reminders sent out prior to the latest webinar. To register, go to www.thewebinarvet.com/hills and enter your details as well as the code hillsnl.

Webinars are ideal for time pressed individuals who may not always be able to travel to a distant venue, yet still offer a 'real- time' and interactive experience. No special equipment is required, other than a reasonable standard PC or MAC and a broadband connection. The events are open to both vets and nurses but early registration is advisable to take full advantage of the whole Hill's Feline webinar series.

Novartis Animal Health has issued the following statement concerning the supply of acepromazine (ACP) injectable in the UK:

"Recent upgrades to Novartis Animal Health’s manufacturing plant in the UK have resulted in the site becoming a worldwide centre of excellence for the production of bulk liquids. This upgrade has had an impact on the manufacture of ACP 2mg/ml and 10mg/ml injectable products, which will no longer be produced in the UK.

From January 2011, Novartis Animal Health will no longer be able to supply ACP Injection 2mg/ml or ACP Injection 10mg/ml to wholesalers. However, it is not Novartis’ intention to discontinue the supply of acepromazine injectable; in order to ensure consistency of supply to the UK market the company will be importing the Vetoquinol French product Calmivet.

Calmivet is a monovalent acepromazine injection licensed for use in dogs, cats and horses, available as a 5mg/ml injection, 50ml vial.

In order to obtain Calmivet from wholesalers, veterinarians will need to apply for a free of charge Special Import Certificate from the VMD. This can be completed on line at www.vmd.gov.uk.

It is anticipated that this situation will continue for at least the first 6 months of 2011, until an alternative manufacturing site is established. As soon as we have more information on the timelines this will be communicated.

A full communication including a prep room reminder poster and Calmivet product leaflet has been mailed to all UK practices.

Vetoquinol UK are not responsible for the distribution or technical support of this product, so any queries should be directed to Novartis Animal Health UK on 01276 694402.

The production and supply of ACP Tablets 10mg remains unaffected."

Dechra Veterinary Products is warning veterinary professionals it is experiencing supply issues with Oxyglobin, Haemoglobin Glutamer-200.

Dechra has supplied Oxyglobin under an exclusive UK distributor agreement with Biopure Corporation since 2002. In 2009, the assets of Biopure Corporation were acquired by OPK Biotech, which has its headquarters in Cambridge, MA, USA. OPK Biotech is working to resume manufacture of Oxyglobin as soon as possible but it is not expected this will happen until well into 2011.

Bob Parmenter, Managing Director of Dechra Veterinary Products, said: "Unfortunately we are now out of stock of Oxyglobin and, due to the supplier's manufacturing issues, we are unlikely to receive new supplies in the immediate future.  I would like to apologise to veterinary professionals for any inconvenience this will cause to their practice but unfortunately this situation is out of our control. We have written to all our Oxyglobin customers to inform them of the position and will keep in contact to advise them when the situation has changed." 

Dechra is advising veterinary professionals that the Pet Blood Bank may be able to offer an alternative product, while Oxyglobin is out of stock. The Pet Blood Bank can be contacted on 01509 232 222, Monday to Friday between 0830 and 1830. The organisation offers a same day and next day delivery service, along with an advice line. Full details of products and services are available by logging on to www.petbloodbank.org

45% of British pet owners believe their four legged friends share their human emotions and can sense when they are upset or unwell, according to a new survey announced by Bayer Animal Health.

The 'Pets are Human Too' study of 3,000 British dog and cat owners was commissioned by the company to celebrate Drontal's www.mypetsuperstar.com competition.

According to the study:

• 32% of cat and dog owners say their pet is a much better listener than their partner.
• 15% of those questioned admit they love their pet so much that they have their dog or cat's image as their own Facebook profile picture, and a quarter have a picture of their pet as their office PC screensaver.
• Forget traditional names like Spot and Scrappy, 33% of the nation would rather give their animal a human name such as Dave, Alan or Sharon.
• One in five pet owners (19%) always sign greetings cards with their pet's paw print, and one in 10 (8%) even throw their dog or cat an annual birthday party, inviting their pets' best friends over for their favourite pet food cake.
• 9% confess to telling their pet a personal secret that they would not have dared to share with their closest human confidants, whilst one in 10 pet owners believes their pet has psychic powers or shares the personality traits of a deceased loved one.
• 41% of dog owners feel that their pet loves them more than their partner, whilst 24% admit they would rather spend quality time with their animal companion over their husband or wife.

TV vet and My Pet Superstar Judge Emma Milne, said: "The joy and companionship our pets bring to our lives is unquestionable and it is no wonder that many consider them to be 'man's best friend'.  Britain is a nation of proud pet owners and now, with the launch of My Pet Superstar, we all have a chance to show them off!"

Bayer Animal Health has announced that its parasiticide -  Advocate Spot-On Solution - is now licensed to be used weekly, and for a prolonged period of time, in severe cases of demodicosis in dogs.

According to the company, recent work carried out to obtain the new weekly indication shows a number of benefits of this increased application frequency for severely affected animals. Dogs treated on a weekly basis showed a greater reduction in mite numbers, fewer clinical signs, and improved hair regrowth and weight gain over the trial period, when compared to dogs treated monthly.

Advocate remains licensed for monthly use on mild to moderate presentations.

A spokesperson for the company said: "The new claim for the weekly use of Advocate should give veterinary surgeons a more effective route to go down when dealing with more severe cases, compared to monthly use. However, demodicosis is a complex condition which presents the practitioner with many challenges. So, from past experience with this condition, we would urge vets to be patient and also recognise the importance of treating any underlying disease process likely to exacerbate the situation."

Advocate Spot-on Solution has also been recently licensed for the prevention of Angiostrongylus vasorum, and the treatment of Crenosoma vulpis.

For further information, please contact your Bayer representative or the Bayer technical advice line on 0845 1305995.

A quick poll carried out by Michael Woodhouse amongst the members of VetSurgeon suggests that the majority of UK veterinary surgeons do not brush their own dog's teeth.

98 members took part in the survey, as follows:

• 6.1% said they brush their own dog's teeth every day
• 5.1% said they brush nearly every day
• 17.3% said they brush less than nearly every day
• 8.2% said they do not brush because, as vets, they can do a free dental!
• 46% answered 'No, but I should'

A study published in the Veterinary Record has shown that Plerion, the broad-spectrum anthelmintic combination preparation for dogs (5 mg pyrantel + 20 mg oxantel + 5 mg praziquantel per kg body weight) is an efficacious and well-tolerated treatment against all important endoparasites, according to manufacturers Intervet Schering-Plough Animal Health. 

In addition, because Plerion is formulated as a flavored chewable tablet, the product was readily consumed by the vast majority of dogs.

Although the product has been on the market in the UK since last year, this is the first time that the evidence for its efficacy has been published in the public domain.

Linda Horspool BVMS, PhD, DipECVPT, MRCVS, Global Technical Director Companion Animal Pharmaceuticals at Intervet/Schering-Plough Animal Health said: "Pyrantel, oxantel and praziquantel, the active ingredients of Plerion, are well-established anthelmintics, having been used successfully in humans and animals for decades. The combination of these ingredients in one preparation offers the possibility to eliminate relevant parasites from most dogs in a single treatment. Moreover, the good palatability of the flavored chewable tablets makes Plerion easy to give and helps owners to remember to treat their dogs regularly which contributes to adequate deworming".

The efficacy, safety and palatability of a single-dose treatment with Plerion were assessed after experimental as well as natural infection with common helminths such as whipworms, tapeworms and roundworms. In five controlled studies (48 treated dogs/49 untreated dogs) and three field studies (30 treated dogs), a total of 127 animals were included. In all comparisons, Plerion-treated dogs had statistically significantly lower worm counts than untreated dogs. Moreover, in treated dogs efficacy against whipworms (Trichuris vulpis) was more than 99 percent after experimental infection and 100 percent after natural infection. For roundworms (Toxocara canis), the corresponding figures were 94 and 100 percent, respectively. For tapeworms (Echinococcus granulosus), the efficacy was more than 99 percent after experimental infection.

The preparation was well-tolerated, evidenced by the finding that treatment of dogs with doses up to 6 times the recommended dose or twice the recommended dose on 3 consecutive days did not result in adverse changes in blood parameters, clinical findings or behavior.

In client-owned dogs, Plerion was readily consumed as demonstrated by the fact that 88 percent of dogs spontaneously accepted the tablet. The proportion of spontaneous acceptance appeared higher than the 78 percent that was obtained with another commercially available flavored reference preparation containing pyrantel, febantel and praziquantel.

Worm infestations in dogs are important parasites in terms of prevalence, pathogenicity and, occasionally, zoonotic impact. Therefore, the European Scientific Counsel on Companion Animal Parasites (ESCCAP) has re-emphasized in its 2010 guideline update titled "Worm Control in Dogs and Cats" that veterinarians and pet owners (1) must take measures to protect pets from parasitic infestations, (2) protect the pet population from risks associated with travel and its consequent potential to change local parasite epidemiological situations through the export or import of non-endemic parasite species, and (3) should work together to reduce the risks associated with zoonotic transmission of parasitic diseases.

*Reference
Schmid K, Rohdich N, Zschiesche E, Kok DJ, Allan MJ. Efficacy, safety and palatability of a new broad-spectrum anthelmintic formulation in dogs. Veterinary Record 2010;167:647-651

Pfizer Animal Health is advising vets and horse owners to be on guard against the threat of West Nile Virus (WNV) in the UK, following a spate of outbreaks of the disease in several European countries this year.

West Nile Virus has recently made headline news because of a human outbreak in Greece which resulted in a number of deaths. Outbreaks have also occurred in Russia, Romania and Italy during 2010. West Nile Fever is a viral disease transmitted by mosquitoes, which carry the virus after biting infected birds. Primarily occurring between July and October, in line with typical peak activity of mosquitoes, it can have serious consequences on human and equine health, with severe cases resulting in fatal neurological disease.

There is no cure, though supportive treatment can aid recovery. However if the disease progresses to a state where the animal is not able to stand up, their chance of survival is considered low. Prevention of infection is difficult, but any steps that reduce mosquito numbers or the likelihood of horses and people being bitten may help to reduce the risk in areas where the disease is present. However, the only way to reduce the risk of an individual horse developing disease due to WNV is through vaccination.

Ben Gaskell, Pfizer's equine veterinary advisor said: "West Nile Virus may well become a very real threat to both horses and humans in Northern Europe. It is important for vets, horse owners and infectious disease experts to work together to mitigate its impact in the event of the virus becoming endemic across Europe. The rapid spread of the disease across North America is an illustration of what could potentially happen in Europe and it is important to remember there is no curative treatment - the only way to prevent clinical disease in horses is by vaccination." 

Pfizer Animal Health supports the PrEquID (Prevention of Equine Infectious Disease) group, which consists of internationally recognised equine and infectious disease experts. The group was formed to develop guidelines on the prevention and control of a number of equine infectious diseases, on a global basis. 

Klaus Osterrieder, Professor and Chair in the Institut für Virologie in the Veterinärfakultät at Freie Universität Berlin, Germany and a member of the PrEquID group advises: "Horse owners should ask their veterinarian for advice on appropriate prevention measures.  Experience has shown that adopting a prudent prevention strategy can be a very effective way of managing this devastating disease."

Further information on WNV is available at www.westnile.eu.

Genitrix has launched a free epilepsy faxback advice service for veterinary practices prescribing Libromide. 

A form downloadable from the Genitrix website will enable practices to provide detailed case histories, and challenging canine epilepsy cases will be reviewed by Dr Clare Rusbridge, RCVS and European Specialist in veterinary neurology. Clare runs a small animal neurology referral practice based at the Stone Lion Veterinary Hospital in South London. She is board certified by the European College of Veterinary Neurology.

Launched earlier this year, Libromide is the first and only licensed formulation of potassium bromide for refractory canine epilepsy. Rob Watkins, Marketing Director at Genitrix, said: "When we launched Libromide, it was our goal to ensure that generalist practices, which may not deal with cases every week, were given more accurate guidance and advice on treating canine epilepsy than was possible when only unlicensed products were available.

"Our subsequent launch of the discounted blood test, the dosing wheel and now the Libromide Epilepsy Advice Service through Clare, are examples of our commitment to achieving this goal.

"The advice service is aimed specifically at practices which are finding it difficult to control seizures or which have a patient experiencing unusual side effects, even after receiving dosing advice from Genitrix. I hope that having Clare's experience and expertise 'on tap' for challenging cases will prove reassuring for our customers."

For more information on the Libromide Epilepsy Advice Service, practices are asked to call Genitrix' head office on 01403 786345.

Fitzpatrick Referrals has announced the launch of a new outpatients diagnostic imaging service, available to all primary care veterinary surgeons. 

According to the practice, its Siemens CT and closed field MRI scanners are among the most advanced in small animal practice in the world, and enable more accurate and timely diagnosis of both routine and potentially life-threatening conditions, including tumours. The practice is now making these scanners available to outpatients from primary care practices.

The service will be available 7 days a week, from 09:00hrs to 21:00hrs. Primary care vets can access the service directly and schedule an appointment at a time convenient to them and their patient, without the need of referral. The qualified team of radiographers at Fitzpatrick will operate the scanners and all scans will be complemented by detailed imaging reports created and sent electronically by Vet CT Specialists, a teleradiology company headed by radiology specialist Victoria Johnson BVSc DVR DipECVDI MRCVS.

Fitzpatrick Referrals says it acknowledges that many primary care veterinary surgeons do not have the resources to provide advanced diagnostic imaging on site, so it is very pleased to be able to offer its CT and MRI suite to help expedite diagnosis, whilst the patient remains under direct supervision by the referring practice and the patient is immediately returned to their care thereafter.  This can be an extension of the service offered by the primary care clinician to the client, hopefully resulting in rapid and appropriate treatment for the patient and expanding the range of services offered by practices to their clients.

Dr Noel Fitzpatrick, Director said: "It's as if the MRI and CT were actually in your own practice, because our facility is just an extension of your care package and you can advertise it as such. This improves the profile of your practice and enhances the bond of the client with the referring practice whilst facilitating appropriate intervention in a timely fashion. All types of scanning, soft tissue, orthopaedic and neurologic, can be catered for and all patients will be cared for and monitored by qualified veterinary nurses at a time to suit the owner. I see this as a win-win situation. If the primary care clinician needs any further help with the case, they can just ask on the day.  Seven-day week advanced diagnostic imaging is now within the grasp of each and every practice, marking a new era of an integrated team approach to efficient cost-effective diagnosis and treatment."

To book an appointment, call Fitzpatrick Referrals on 01483 423761 and in due course there will be an online booking facility.  For more information on the Outpatients Diagnostic Imaging Service, call Simon Hester on 07802 584133 or visit www.fitzpatrickreferrals.co.uk.

Dechra Veterinary Products has launched a new CPD programme covering Feline Hyperthryoidism, Canine Hyperadrenoncorticism and Otitis Externa.

The CPD is available both as face-to-face sessions, and online at http://www.dechra.com/

The face-to-face sessions are taking place at various locations throughout the country and run until the end of June 2011. There is no charge for veterinary surgeons and nurses to attend, and each session counts as two hours CPD.

The Feline Hyperthyroidism CPD session will cover pathophysiology, clinical signs, diagnosis and treatment options. The Hyperadrencorticism CPD will focus on the diagnosis and treament of hyperadrenocorticism. The Otitis Externa CPD event will focus on the approach to acute cases, with subjects including ear anatomy and physiology, causes of otitis externa and treatments available.  Two cases studies, developed in association with Peter Forsythe, an RCVS Recognised Specialist in Veterinary Dermatology, will provide practical advice on how to manage dogs with otitis externa in practice.  

To find out more about Dechra's CPD sessions or reserve places, call Lisa Isherwood on 01939 211 200.